Follow the BB Biotech AG stock price and the full insider trade history of the company, a listed issuer based in Switzerland. Shares trade on CH CH, under the oversight of SIX SER. Operating in the Health Care sector, BB Biotech AG has logged 7 public disclosures. Market capitalisation: €2.5bn. The latest transaction was reported on 5 March 2025 (Purchase). Among the most active insiders: Anonymous (Non-executive member of the board of directors). The full history is openly available.
7
Insider Decl.
0
Thresholds
€1m
7 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Buys €1m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 29 of 26,132 companies
94.2
score / 100
Value
91
Quality
98
FCF yld11%
Earn yld20%
EV/EBITDA·
ROE35%
Gross mgn·
Net mgn98%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2025
Declarations7 total
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directors·Executives·